Abstract-We have shown previously that activation of protein kinase C-␦ (PKC␦) is required for angiotensin II (Ang II)-induced migration of vascular smooth muscle cells (VSMCs). Here, we have hypothesized that PKC␦ phosphorylation at Tyr 311 plays a critical role in VSMC hypertrophy induced by Ang II. Immunoblotting was used to monitor PKC␦ phosphorylation at Tyr 311 , and cell size and protein measurements were used to detect hypertrophy in VSMCs. PKC␦ was rapidly (0.5 to 10.0 minutes) phosphorylated at Tyr 311 by Ang II. This phosphorylation was markedly blocked by an Src family kinase inhibitor and dominant-negative Src but not by an epidermal growth factor receptor kinase inhibitor. Ang II-induced Akt phosphorylation and hypertrophic responses were significantly enhanced in VSMCs expressing PKC␦ wild-type compared with VSMCs expressing control vector, whereas the enhancements were markedly diminished in VSMCs expressing a PKC␦ Y311F mutant. Also, these responses were significantly inhibited in VSMCs expressing kinase-inactive PKC␦ K376A compared with VSMCs expressing control vector. From these data, we conclude that not only PKC␦ kinase activation but also the Src-dependent Tyr 311 phosphorylation contributes to Akt activation and subsequent VSMC hypertrophy induced by Ang II, thus signifying a novel molecular mechanism for enhancement of cardiovascular diseases induced by Ang II. (Hypertension. 2008;51:232-238.)
Increasing evidence suggest that PKC␦ is involved in many mechanisms promoting VSMC remodeling and dysfunction. 8 -11 It was reported that PKC␦ is activated by mechanical stress, and VSMCs from PKC␦-null mice migrate slower than control VSMCs. 12 Previously, we have shown that PKC␦ kinase activity is required for activation of several tyrosine kinases by Ang II or reactive oxygen species in VSMCs. 4, 13, 14 Moreover, we have reported recently that PKC␦ is required for activation of Rho, Rho-kinase and c-Jun NH 2 -terminal kinase and subsequent migration of VSMCs by using kinase-inactive PKC␦ overexpression. 15 These data suggest an important role of PKC␦ in mediating vascular remodeling induced by Ang II.
PKC␦ is also phosphorylated on tyrosine residues in many cells, including VSMCs and cardiac myocytes. 13,16 -18 may also affect the selectivity of substrates. 17 Taken together with the above information, we have tested the hypothesis that PKC␦ Tyr 311 phosphorylation plays a major role in Ang II-induced vascular hypertrophy. We found that PKC␦ phosphorylation at Tyr 311 was induced by Ang II through a Src family kinase and that this phosphorylation was involved in Akt activation and subsequent VSMC hypertrophy.
Materials and Methods
An expanded Methods section describing reagents, primary antibodies, cell culture, and statistical analysis is available at http://hyper.ahajournals.org.
Retrovirus Infection
Wild-type or Y311F PKC␦ containing enhanced green fluorescent protein (GFP) at the C terminus 20 was cloned into the pBM-IRES-PURO vector, and high titer retroviral supernatants were generated. 21 VSMCs were infected with retrovirus, and the infected VSMCs were selected as described previously. 22, 23 To assess complete viral transformation after an antibiotic selection, in addition to the detection of the overexpression by immunoblotting, we routinely confirmed Ͼ99% infection efficiency of our retrovirus vectors by the GFP tagged to the mutants and detected under a fluorescent microscope.
Adenovirus Infection
The generation of adenovirus encoding wild-type and a kinaseinactive K376A PKC␦ mutant construct and dominant-negative K295MϩY527F Src was described previously. 24, 25 The titer (plaque-forming units per milliliter) of adenovirus was determined by Adeno-XTM Rapid Titer kit (BD Biosciences). VSMCs were infected with adenovirus for 2 days, as described previously. 14 To assess complete viral transformation, we routinely confirmed Ͼ99% infection efficiency of our adenovirus vectors by GFP encoded by these vectors separately and detected under a fluorescent microscope.
Immunoblotting
Cell lysates were subjected to SDS-PAGE and transferred to a nitrocellulose membrane, as described previously. 26 The membranes were then exposed to primary antibodies overnight at 4°C. After incubation with the peroxidase-linked secondary antibody (Amersham Biosciences) with dilution between 1:1000 and 1:10 000 (depending on the primary antibody) for 1 hour at room temperature, the immunoreactive proteins were visualized by a chemiluminescence reaction kit (Pierce).
Protein Assay
VSMCs on 12-well culture plates were incubated with serum-free DMEM for 3 days in retrovirus-infected VSMCs. For adenovirus infection, VSMCs were incubated with serum-free DMEM for 1 day and infected with adenovirus at 100 multiplicity of infection in serum-free DMEM for 2 days. The cells were further incubated with or without 100 nmol/L of Ang II for 3 days. After aspiration of the medium, cells were washed twice with ice-cold Hanks' balanced salt solution, and the total amount of cellular protein was measured as described previously. 27 
Cell Volume Assay
After the pretreatments described in the protein assay, VSMCs were washed with Hanks' balanced salt solution and trypsinized. The cells were then suspended in PBS, and the cell volume was measured by Z2 Coulter Particle Count and Size Analyzer (Beckman Coulter). 27 
Proliferation Assay
After the pretreatments described in the protein assay, cell proliferation was measured using a CellTiter 96 Aqueous cell proliferation assay kit (Promega), following the manufacturer's protocol, as described previously. 27 Basically, this assay measures cell viabilities on the PKC␦ manipulation with or without Ang II stimulation for 3 days.
5-Bromodeoxyuridine Assay
After the adenovirus infection, as described for the protein assay, the cells were pretreated with or without 100 nmol/L of Ang II for 24 hours, and 5-bromodeoxyuridine incorporation was determined for an additional 24 hours by a 5-bromodeoxyuridine incorporation kit (Calbiochem) according to the manufacturer's protocol.
Results
Phosphorylation of PKC␦ at Tyr 311 by Ang II Through the G q -Coupled AT 1 
Receptor
In 3-day serum-starved rat aortic VSMCs, Ang II (100 nmol/L) stimulated phosphorylation of PKC␦ at Tyr 311 in a rapid (within 30 seconds) and transient manner with a peak of 2 to 5 minutes (Figure 1 ). The phosphorylation returned to the baseline level at 40 minutes ( Figure S1A ). Thus, in subsequent experiments, unless otherwise stated, VSMCs were stimulated with Ang II for 2 minutes for evaluation of the PKC␦ phosphorylation. Pretreatment with an AT 1 receptor antagonist, RNH6270, totally blocked PKC␦ phosphorylation by Ang II ( Figure S1B ). The AT 1 receptor is mainly coupled to the heterotrimeric G protein G q , whereas G proteinindependent signal transduction by the AT 1 has been reported. 2 Thus, we determined whether G q contributed to the Ang II-induced PKC␦ phosphorylation. Pretreatment with a selective G q inhibitor, YM-254890, 22, 28 completely blocked PKC␦ phosphorylation at Tyr 311 by Ang II ( Figure S1C ), indicating that Ang II-induced phosphorylation of PKC␦ at Tyr 311 was mediated through G q activation.
Involvement of Src in PKC␦ Tyr

311
Phosphorylation by Ang II Activation of the AT 1 receptor by Ang II leads to rapid transactivation of the epidermal growth factor (EGF) recep- tor, which seems to mediate many key components of downstream signal transduction in VSMCs, 29 whereas an Src family kinase has been implicated as a PKC␦ Tyr 311 kinase. 17 To clarify the involvement of Src family kinase and/or EGF receptor transactivation in PKC␦ phosphorylation, we pretreated VSMCs with PP2, an Src family kinase inhibitor, or AG1478, an EGF receptor family kinase inhibitor. Interestingly, Ang II-induced PKC␦ Tyr 311 phosphorylation was markedly blocked by PP2 (5 mol/L), whereas AG1478 (1 mol/L) had no inhibitory effect. As expected, AG1478, but not PP2, inhibited Ang II-induced EGF receptor transactivation as detected by its autophosphorylation at Tyr 1068 ( Figure 2A ). Also, PP3 (5 mol/L), the inactive control chemical for PP2, had no inhibitory effect on Ang II-induced PKC␦ Tyr 311 phosphorylation ( Figure S1D ). To support these pharmacological experiments, the effect of dominantnegative Src was examined. Infection of adenovirus encoding dominant-negative Src, but not the control vector, markedly inhibited PKC␦ Tyr 311 phosphorylation induced by Ang II, whereas neither virus affected the EGF receptor transactivation ( Figure 2B ). Sufficient overexpression of the dominantnegative Src mutant, as compared with endogenous Src, was confirmed ( Figure 2B ). These data suggest that Src, but not the EGF receptor, mediates Ang II-induced PKC␦ Tyr 311 phosphorylation.
Involvement of PKC␦ Tyr 311 Phosphorylation and PKC␦ Kinase Activity in Ang II-Induced VSMC Hypertrophy
To verify the functional significance of the Tyr 311 phosphorylation, we established VSMCs that overexpress wild-type PKC␦ or a PKC␦ Y311F mutant containing GFP at the C terminus using retrovirus infection ( Figure 3A ). In wild-type PKC␦ expressing VSMCs, the Ang II-induced increase in cellular protein was significantly enhanced compared with the control VSMCs. However, the enhancement was much less in Y311F-expressing VSMCs ( Figure 3B ). Moreover, in wild-type PKC␦ VSMCs, Ang II significantly increased the cell volume, whereas no enhancement was observed in Y311F mutant-expressing cells ( Figure S2A ). There was no significant change in cell number among these VSMCs stimulated by Ang II ( Figure S2B ). The confluence state of these VSMCs at the time of the measurements was Ͻ90%, because without a mitogen, the VSMC did not significantly proliferate after serum starvation. Also, 5-bromodeoxyuridine incorporation was not significantly changed by Ang II, regardless of wild-type PKC␦ overexpression in VSMCs ( Figure S2C ). In addition, there was no enhancement of an apoptotic marker, cleaved caspase-3, detected in either control or PKC␦ overexpressing VSMCs with 4 hours of Ang II stimulation ( Figure S3 ).
To investigate whether the kinase activity of PKC␦ is also required for Ang II-induced protein synthesis in VSMCs, we infected VSMCs with an adenovirus encoding a kinaseinactive PKC␦ mutant (K376A). In VSMCs expressing K376A, both Ang II-induced protein synthesis (Figure 4 ) and the increase in cell volume ( Figure S4A ) were significantly inhibited compared with control VSMCs. Again, there was no significant change in cell number among these VSMCs stimulated by Ang II ( Figure S4B ). These data suggest that PKC␦ Tyr 311 phosphorylation and PKC␦ kinase activity are both required for Ang II-induced hypertrophy in VSMCs.
It has been demonstrated that both Akt and extracellular signal regulated kinase (ERK) 1/2 are involved in Ang II-induced VSMC hypertrophy. 30 -32 To assess the functional role of PKC␦ Tyr 311 phosphorylation and kinase activity in Ang II-induced hypertrophic signaling, we examined Akt and ERK 1/2 activation in the above-treated cells. In wild-type PKC␦ expressing VSMCs, Ang II-induced Akt phosphorylation was markedly enhanced, whereas no enhancement of Akt phosphorylation by Ang II was seen in Y311F-expressing VSMCs ( Figure 5A ). In contrast, neither wildtype nor Y311F expression altered Ang II-induced ERK phosphorylation in VSMCs. Also, PKC␦ Tyr 311 phosphorylation by Ang II precedes the Akt phosphorylation. We have demonstrated previously that K376A PKC␦ had no inhibitory effect on ERK 1/2 phosphorylation induced by Ang II in VSMCs. 15 In contrast, Akt phosphorylation induced by Ang II was markedly inhibited in K376A-expressing VSMCs ( Figure 5B ). These data suggest that Ang II-induced VSMC hypertrophy is positively regulated by PKC␦ kinase activation and Tyr 311 phosphorylation through their involvement with Akt activation but not ERK activation.
Discussion
The major novel findings of this study revealed that PKC␦ activation associated with Tyr 311 phosphorylation mediates Ang II-induced VSMC hypertrophy through a mechanism involving Akt. Also, Ang II seems to induce PKC␦ Tyr 311 phosphorylation through the G q -coupled AT 1 receptor via Src. These findings provide a new signaling mechanism by which 
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the AT 1 receptor activation leads to PKC␦-mediated vascular remodeling and may serve as a potential therapeutic target toward cardiovascular diseases. Ang II-induced rapid PKC␦ Tyr 311 phosphorylation has been reported 18 with a slightly more sustained time course, which may be because of a shorter serum starvation than in the present study. However, the upstream regulators of PKC␦ Tyr 311 phosphorylation have not yet been identified. The present study using a selective G q inhibitor indicates that the phosphorylation is mediated through G q activation. This is in agreement with our recent observation suggesting that Ang II-induced PKC␦ Tyr 311 phosphorylation in VSMCs requires intracellular Ca 2ϩ elevation. 33 Because the AT 1 receptor is the dominant receptor expressed in our cultured VSMCs, 34 we have not evaluated the possible confounding of these signal transductions by the AT 2 receptor. Increasing evidence suggests the counterregulatory functions of the AT 2 receptors toward the AT 1 receptor-dependent functions, including vascular hypertrophy, as well as hyperplasia in vivo. 35, 36 Therefore, it will be interesting to further characterize a possible signal cross-talk of the PKC␦ regulation between these subtype receptors in vivo.
Here, we report that PKC␦ phosphorylation at Tyr 311 by Ang II is at least in part Src dependent in VSMCs. Supporting this finding is the fact that several others have reported that PKC␦ Tyr 311 phosphorylation in select cell types depended on Src family kinases when stimulated with various non-G protein-coupled receptor agonists. 19, 37, 38 Also, Src family kinases have been shown to be complexed with PKC␦ in several cell types, including VSMCs. 13,38 -40 However, possible contribution of other Src family kinases (Fyn and yes) expressed in VSMCs 41 in Ang II-induced PKC␦ Tyr 311 phosphorylation remains to be determined. Although we have not studied Ang II-induced Src phosphorylation, such as at the positive regulatory Tyr 416 residue, the Src inhibitor PP2 used in this study has been shown to block this phosphorylation effectively in VSMCs. 42, 43 In addition, our data suggest that the involvement of EGF receptor transactivation in the PKC␦ phosphorylation by Ang II is unlikely. However, the EGF receptor kinase inhibitor AG1478, if used at 10 times more concentration than in the present study, partially attenuated c-Src phosphorylation at Tyr 416 induced by Ang II in VSMCs. 42 Thus, further careful evaluation may be necessary regarding the possible partial but minor involvement of the EGF receptor transactivation in this PKC␦ cascade.
We have previously used a PKC␦ inhibitor, rottlerin, to elucidate the role of this PKC isoform in signal transductions of the AT 1 receptor in VSMCs. 4, 15 However, we have not used this inhibitor in the present study because of the reported off-target effects, 44 which would be inappropriate for our long-term hypertrophic experiments. In PKC␦-deficient VSMCs, cytoskeletal signaling, reorganization, and subsequent migration in response to mechanical stress were diminished. 12 Also, an overexpression study using the wild-type PKC␦ suggested that PKC␦ mediates p38 mitogen-activated protein kinase activation induced by high glucose in VSMCs. 45 However, by using the K376A mutant, as well as rottlerin, our previous studies have shown that PKC␦ kinase activity is essential for Ang II-induced activation of a select set of protein kinases, which include JAK2, Rho-kinase, p21-activated kinase, and c-Jun NH 2 -terminal kinase but not ERK or p38 mitogen-activated protein kinase. 14, 15, 33 Thus, involvement of PKC␦ in p38 mitogen-activated protein kinase activation may be agonist dependent.
It has been reported that PKC␦-deficient mouse VSMCs are resistant to apoptotic responses compared with control VSMCs. 46 Overexpression of PKC␦ in VSMC cell lines also results in G1 arrest and apoptosis. 10, 47 These apoptotic or necrotic changes, if they occur, could be associated with enlargement of cell volume. 48 However, this scenario is quite unlikely in our present study, because there was no difference in caspase-3 cleavage or cell viability with PKC␦ overexpression regardless of Ang II stimulation, as shown in Figure S3 .
Here, we further revealed Akt as a PKC␦-dependent kinase in VSMCs stimulated by Ang II, which plays a significant role in VSMC hypertrophy. 31 To support our notion, a similar link between PKC␦ and Akt was observed in thrombininduced nuclear factor B activation in endothelial cells. 49 In addition, other mechanisms may coordinately regulate VSMC hypertrophy on PKC␦ activation by Ang II, such as expression of Smad3 and transforming growth factor-␤, 11 and the Tyr 311 phosphorylation of PKC␦. Interestingly, our data suggest that Ang II-induced PKC␦ Tyr 311 phosphorylation is also required for enhanced Akt activation and VSMC hypertrophy observed in VSMCs overexpressing wild-type PKC␦. However, the PKC␦ Y311F mutant did not show a dominant-negative effect to inhibit Akt activation below the vector-transfected cells, and one of the hypertrophic responses was still slightly greater than the control cells, demonstrating distinct characteristics of the PKC␦ mutants. The kinase-inactive mutant, K376A, not only loses its wild-type ability to positively regulate Akt activation and subsequent hypertrophy but also competes with endogenous PKC␦ and, thus, acts as a dominant-negative PKC␦ inhibitor. Y311F mutant also loses most of its own hypertrophic characteristics, whereas it is unable to interfere with the endogenous wild-type PKC␦. Although PKC␦ Tyr 311 phosphorylation has been proposed to enhance kinase activity, recent findings suggest additional roles of the Tyr 311 phosphorylation in mediating unique functions of this PKC isoform. 17, 50 The Tyr 311 phosphorylation may be the additional component required for the complex formation among PKC␦, Akt, and its upstream kinase, 3-phosphoinositidedependent kinase 1/3-phosphoinositide-dependent kinase 1 and subsequent Akt activation, which seems to require the PKC␦ kinase activity. 51 Taken together, it is attractive to speculate that the PKC␦ phosphorylation may contribute to Akt activation and subsequent hypertrophy independent from the kinase activity. To support this notion, we observed a comparable autophosphorylation of Y311F PKC␦ at Ser 643/676 phosphorylation to that of wild-type in Ang II-stimulated VSMCs (unpublished observation), thus reflecting the kinase activity remains intact in the Y311F mutant.
In the present study, we have not used a standard protein synthesis assay measuring a radiolabeled leucine incorporation. However, we believe that our 2 distinct methods used here measure the hypertrophic effects of Ang II just as sufficiently and perhaps more directly. Our data demonstrat-ing hypertrophic responses by Ang II stimulation in VSMCs are consistent with highly sited past articles using intact aortic segments 52 and cultured aortic VSMCs. 53 Moreover, no significant enhancement of DNA synthesis was observed in Ang II-stimulated VSMCs regardless of PKC␦ overexpression. However, because our data rely on overexpression strategies, a future study should be conducted by using specific RNA silencing to evaluate the overall roles of PKC␦ in mediating VSMC hypertrophy induced by Ang II. In addition, slight distinctions in control cell responses between Figures 3B and 4A may be caused by distinct control vectors used, as well as by a selection of the permanently infected cells in the retroviral experiment. It is also unlikely that the PKC␦ Y311F mutant affects other PKC isoforms expressed in VSMCs nonspecifically, because this residue is unique to PKC␦. Other than the data shown in Figure 3A , we and others have demonstrated previously the specificities of the PKC␦ mutants used in the present study. 14,50,54 -56 A recent study using proteomic analysis of PKC␦-deficient VSMCs revealed that Ͼ30 proteins are altered, including enzymes related to glucose and lipid metabolism, thus highlighting the critical role of PKC␦ in the development of cardiovascular diseases. 9 PKC␦ activation increases O 2 derived free radical generation from mitochondria and thereby promotes a pro-oxidant state. 57 Therefore, it will be interesting to expand the present findings by evaluating the regulation of proteins, such as pyruvate dehydrogenase and heat shock proteins, which are likely involved in atherosclerosis, as well as metabolic disorders. 58, 59 Perspectives We found that, in addition to PKC␦ kinase activity, PKC␦ phosphorylation at Tyr 311 seems to be required for Akt activation and subsequent VSMC hypertrophy induced by Ang II, which is considered a potential mechanism of atherosclerosis and restenosis after vascular injury. However, our findings are limited within cell culture experiments. Therefore, further clarification of the signal transduction in vivo could contribute to a better understanding of the molecular mechanism of cardiovascular diseases, as well as to the development of better strategies for their treatment. 
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